Companies

Who we bring together sets us apart

Companies

    Our tenants span the life science sector, including therapeutics, diagnostics, medical devices, and research tools. They learn from and support each other, often forming partnerships.

    Scientists working
    Overview

    Get to know our tenants, the
    hardworking innovators at the
    core of our community.

    View our job listings

    Tenant Spotlights

     View all spotlights

    Learn more about
    their stories

    The Bakar ClimatEnginuity Hub, expected to open during the 2027-2028 academic year, will provide a home for entrepreneurs in the burgeoning field of climate technology. The donor-funded facility will be located on the west side of campus at the site currently occupied by University Hall. Rendering by Gensler

    Bakar ClimatEnginuity Hub: Berkeley’s New Home for Climate Innovation

    A new incubator on the west side of campus will provide resources and support to entrepreneurs in renewable energy and clean technology. Read post
    Graphic depiction of robot hand editing DNA

    The AI Effect: How a Hot Computing Tool Is Tying ‘Bio’ and ‘Tech’ Closer Than Ever

    “In protein design, until the last couple of years, successes were rare,” said Fraser, a professor of bioengineering and therapeutic sciences in UCSF’s School of Pharmacy. “(AI has) just been a sea change. Stuff works now.” Those successes are elevating a new generation of AI-focused drug-development companies in the Bay Area, including Profluent Bio, a 20-person Berkeley startup founded by the leaders of the Salesforce project. In the wake created by ChatGPT and a wealth of biological data, those companies may be key to AI’s evolving ability to fix human ills. Read post
    Sophia Lugo

    Startup Launches With ‘RNA Sensor’ Technology From Stanford and MIT To Better Control mRNA Therapies

    “We want to turn off an RNA transcript and prevent it from being expressed by default,” CSO Eerik Kaseniit, a former graduate student who worked on the technology in Gao’s lab, told Endpoints News in an interview. Radar’s scientists do that by adding a stop codon — three genetic letters that are the molecular equivalent of a red light — in front of the mRNA therapy, which prevents cells from reading the message. Read post
    Illustration of hands exchanging money for lightbulb

    Jim Collins’ Latest Venture Raises $13.4M To Programme Logic-Gated mRNA Therapies

    Radar Therapeutics thinks it can push the technology to the next level – and into more diseases – with safety switches that boost cell specificity, safety, and accessibility. The biotech, co-founded by MIT professor and synthetic biology pioneer Jim Collins, launched Thursday with a $13.4-million seed round led by NfX Bio and boasting Eli Lilly as one of its investors. Read post
    Illustration of person climbing ladder to reach into bush shaped like double helix

    Radar Therapeutics Raises $13 Million to Design Therapies Using RNA Sensors

    Radar Therapeutics emerged from stealth this week with an announcement that it had raised $13.4 million in an oversubscribed seed financing round led by NfX Bio. Eli Lilly & Co, Biovision, and KdT Ventures also joined the round, with participation from PearVC, BEVC, and other investors. They will use the funds to advance various internal programs, expand their team, and pursue partnership opportunities. Read post
    Sampling Human apoptosis kit

    Sampling Human Ships its First Kits for Cellular Analysis to Early Access Customers and Releases an App Note with BMG LABTECH

    Daniel Georgiev, co-founder and chief executive officer of Sampling Human, will be speaking on applications for the technology at the SynBioBeta conference. “At Sampling Human, we recognize the great lengths scientists go to today in order to obtain high-quality single-cell data,” said Daniel Georgiev. “Our plug and play products are designed to deliver reliable solutions with higher specificity, lower cost and ease of use for measuring the growing number of specialized cells in the body.” Read post
    Scientist
    Want to learn more?

    Become a tenant at Bakar Labs

    Get in touch